AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7395
+0.0145 (2.00%)
Sep 9, 2025, 12:47 PM - Market open
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $8.61 million as of September 9, 2025. Its market cap has decreased by -77.99% in one year.
Market Cap
8.61M
Enterprise Value
16.44M
1-Year Change
-77.99%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $8.61M, a decrease of -86.47%. That is a compound annual growth rate of -36.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 8.44M | -60.89% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |